Eli Lilly
1,949 hedge funds and large institutions have $148B invested in Eli Lilly in 2021 Q1 according to their latest regulatory filings, with 180 funds opening new positions, 673 increasing their positions, 778 reducing their positions, and 99 closing their positions.
82% more first-time investments, than exits
New positions opened: 180 | Existing positions closed: 99
11% more capital invested
Capital invested by funds: $133B → $148B (+$15.1B)
3% more funds holding
Funds holding: 1,887 → 1,949 (+62)
0.47% more ownership
Funds ownership: 82.26% → 82.73% (+0.47%)
4% less funds holding in top 10
Funds holding in top 10: 48 → 46 (-2)
13% less repeat investments, than reductions
Existing positions increased: 673 | Existing positions reduced: 778
14% less call options, than puts
Call options by funds: $971M | Put options by funds: $1.13B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$2.75B |
| 2 |
Capital World Investors
Los Angeles,
California
|
+$2.3B |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.02B |
| 4 |
Jennison Associates
New York
|
+$697M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
+$212M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$818M |
| 2 |
Capital International Investors
Los Angeles,
California
|
-$484M |
| 3 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$409M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$394M |
| 5 |
Winslow Capital Management
Minneapolis,
Minnesota
|
-$328M |
LLY Hedge Fund Activity: Q1 2021 in Review
1,949 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Eli Lilly (LLY) for Q1 2021, worth a combined $148B — up 11% from $133B a quarter earlier.
Buyers outnumbered sellers: 180 funds opened new LLY positions and 99 closed out — a net gain of 81 holders — while 673 added to existing stakes and 778 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $2.75B. The largest seller was JP Morgan Chase, cutting an estimated $818M.
- 1,949 institutional investors held Eli Lilly (LLY) as of Q1 2021, up from 1,887 in Q4 2020.
- Funds reported $148B of Eli Lilly stock for Q1 2021, up 11% quarter-over-quarter.
- 180 funds opened new Eli Lilly positions in Q1 2021 and 99 closed out, a net change of +81 holders.
- The largest Eli Lilly buyer in Q1 2021 was T. Rowe Price Associates, an estimated $2.75B added.
- The largest Eli Lilly seller in Q1 2021 was JP Morgan Chase, an estimated $818M sold.
Based on aggregated 13F filings for Q1 2021.